TWiV 1008: Clinical update with Dr. Daniel Griffin

This Week in Virology

Vincent Racaniello

Vincent, Microbe, Medicine, Microbiology, Racaniello, Infection, Virus, Virology, Pathogen, Infectious, Twiv, Science & Medicine

4.8 • 2.2K Ratings

🗓️ 20 May 2023

⏱️ 32 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID) Ventilation in buildings (CDC) COVID-19 mortality among SSRI users (CMI) Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP) Trajectories of the evolution of post COVID-19 condition (IJID) Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1008 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Transcript

Click on a timestamp to play from that location

0:00.0	This week in virology, the podcast about viruses, the kind that make you sick.
0:10.4	From microTV, this is TWIV, this week in virology episode one thousand eight recorded on May 18th,
0:20.5	twenty twenty three. I'm Jensit Racken yellow and you're listening to the podcast all about viruses
0:28.3	joining me today from New York, Daniel Griffin. Hello everyone. I'm joining you from Geneva, Switzerland.
0:39.9	Yeah, it's a different different background. I was, you know, I should have remembered it's only
0:44.5	been a few days since you told me you were headed there. So just got off a four-day
0:50.0	Nido virus meeting, which was really, really cool. And at the end, maybe this is something you'll
0:56.2	cover next time, may a WHO announced its new booster policy. Yeah, you were there for that. And yes,
1:05.3	it was, you know, we'll just mention slightly, but yeah, we'll discuss that more next time. But let
1:10.9	me start with my quotation, less is only more where more is no good. That's a Frank Lloyd Wright
1:18.2	quotation. Yeah, I'm always a little thrown by his architecture and his quotations, but we'll see
1:24.0	what we can make of that. And you'll later on perhaps understand why I throw that in. So I'm
1:29.5	going to jump right into COVID, you know, and people ask like, how's it going? What's happening
1:34.9	out there? And I think I mentioned this last time and just to reinforce, we do not have as much
1:39.8	information about what's going on right now. We're just tracking weekly COVID-19 hospital admission
1:46.1	levels percentage of all COVID-19 associated deaths. And then we have some secondary information,
1:52.4	emergency department visits, hopefully that's kind of about early flag if something's happening there.
1:57.8	percentage of positive SARS-CoV-2 laboratory tests. And we're still going to get, be getting
2:02.8	genomic surveillance still seeing some folks in the hospital with COVID. So it is certainly still
2:09.9	with us. But I want to move right into testing. Because this is a question, I think it's a
2:15.7	perennial question. And I will get right into it with the article virus variant specific clinical
2:21.9	performance of a SARS-CoV-2 rapid antigen test with focus on Omicron VOC recently published in CID.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vincent Racaniello, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vincent Racaniello and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.